Burnett, A.L., Bivalacqua, T.J., Champion, H.C. and Musicki, B. (2006) Long-Term Oral Phosphodiesterase 5 Inhibitor Therapy Recurrent Alleviates Priapism. Urology, 67, 1043-1048.
https://doi.org/10.1016/j.urology.2005.11.045

has been cited by the following article:

• TITLE: Management of Venous Priapism: Experience of Sylvanus Olympio University Hospital in Lomé (TOGO)

  AUTHORS: Komi Hola Sikpa, Edoe Viyome Sewa, Efoe-Ga Amouzou, Gnimdou Botcho, Ananivi Sogan, Tamegnon Dossouvi, Essodina Padja, Boureima Ouedraogo, Essomindelou Leloua, Messan Semefa Agbedey, Tchilabalo Matchonna Kpatcha, Kevin Kodjo Tengue

  KEYWORDS: Venous Priapism, Urgency, Drepanocytosis, Neuroleptics, Erectile Dysfunction

  JOURNAL NAME: Open Journal of Urology, Vol.8 No.10, October 29, 2018

  ABSTRACT: Objective: To study the diagnostic, etiological, therapeutic and evolutionary aspects of patients received at the Sylvanus Olympio Hospital in Lomé for venous priapism. Patients and Methods: A cross sectional study, over 5 years (2012-2016), of 27 cases of low flow priapism treated at the Chu Sylvanus Olympio in Lomé. Results: The mean age of the patients was 28.14 years ± 8.6. The average time of consultation was 106 hours (04 days 10 hours) ± 208.02. In our study, 4 (14.81%) patients consulted before the 6th hour and 20 (74%) patients consulted after the 24th hour. The blood count required in all patients revealed a case of chronic myeloid leukemia. Hemoglobin electrophoresis resulted in 23 (85.1%) cases of sickle cell disease. The management was medico-surgical. After an average follow-up of 11 months, erectile function was evaluated in 18 patients, and erectile dysfunction was noted in 10 (55.5%) patients.